Learn More
Human BRCA2 Antibody, R&D Systems™

Description
Specifications
Specifications
| Antigen | BRCA2 |
| Applications | Western Blot, Immunohistochemistry |
| Classification | Monoclonal |
| Clone | 234403 |
| Concentration | LYOPH |
| Conjugate | Unconjugated |
| Dilution | Western Blot 0.2 ug/mL, Immunohistochemistry 8-25 ug/mL |
| Formulation | Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative |
| Gene Accession No. | P51587 |
| Gene Alias | BRCA1/BRCA2-containing complex, subunit 2, BRCC2, breast and ovarian cancer susceptibility gene, early onset, breast cancer 2 tumor suppressor, breast cancer 2, early onset, breast cancer susceptibility protein BRCA2, breast cancer type 2 susceptibility protein, BROVCA2, FACD, FAD, FAD1, FANCB, FANCD, FANCD1Fanconi anemia, complementation group D1, Fanconi anemia group D1 protein, GLM3, PNCA2 |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.